Gene · 100126325
MIR935: microRNA 935
12 sourcesgene-search-2026-11-11-0.2.0
Download JSON
Cite this record
ConductScience Library. MIR935: microRNA 935. Genes, record 100126325. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/100126325
On this page
Gene
Proteins0
Reviewed human proteins whose Swiss-Prot entry states the gene.
None in this release.
Patents0
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
None in this release.
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants308
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | MIR935 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016042 | Cancer Center Support Grant | 2 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 2 | 2025 |
| P30CA023074 | University of Arizona Cancer Center - Cancer Center Support Grant | 2 | 2025 |
| P30CA056036 | Translational Research in Cancer | 2 | 2025 |
| P30DK092924 | Diabetes Research and Engagement through Advanced Multilevel Science Center for Diabetes Translational Research (DREAMS-CDTR) | 2 | 2025 |
| U01CA200466 | Validation of biomarkers for risk prediction and early diagnosis of Pancreatic Adenocarcinoma | 2 | 2025 |
| ZIAAG000519 | The Underlying Biology of Health Disparities | 2 | 2025 |
| P01AG036675 | Kynurenine accumulation drives loss of muscle and bone function with aging | 1 | 2025 |
| P20GM103499 | South Carolina IDeA Networks of Biomedical Research Excellence (SC INBRE) | 1 | 2025 |
| P20GM109024 | Center for Diagnostic and Therapeutic Strategies in Pancreatic Cancer | 1 | 2025 |
1 to 10 of 308Source NIH's project files
See all 308 nih grantsPapers1,500
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Serum exosomal miRNA signature in hypertension: an exploratory study integrating with comparative analysis of the GEO database. | Mol Cell Biochem | 2026 | 42803867 | PubTator, text mining | PubMed |
| A Pan-Cancer Analysis of microRNA Tissue Specificity and Its Association with Dysregulation. | Int J Mol Sci | 2026 | 42794582 | PubTator, text mining | PubMed |
| Circulating Extracellular Vesicle Biomarkers in Chronic Lymphocytic Leukemia: A Preliminary Study on Their Diagnostic, Prognostic, and Predictive Relevance. | Biomolecules | 2026 | 42793125 | PubTator, text mining | PubMed |
| PCBP2 facilitates miR-93-5p-mediated repression of GDF11 in HCC cell lines. | Mol Ther Nucleic Acids | 2026 | 42732236 | PubTator, text mining | PubMed |
| Placental Extracellular Vesicles in Preeclampsia: Molecular Cargo, Pathophysiological Roles, and Emerging Diagnostic and Therapeutic Frontiers. | Am J Reprod Immunol | 2026 | 42667637 | PubTator, text mining | PubMed |
| Circulating microRNAs as biomarkers of disease activity and treatment response in Crohn's disease patients receiving infliximab or vedolizumab: a longitudinal cohort study. | Front Med (Lausanne) | 2026 | 42661642 | PubTator, text mining | PubMed |
| Protective Effect of lncRNA FGD5-AS1 Against Brain Injury After Intracerebral Hemorrhage by Targeting miR-93-5p. | J Vis Exp | 2026 | 42612047 | PubTator, text mining | PubMed |
| Coordinated Transcriptional Repression of CAV1 and CAV2 in Thoracic Aortic Aneurysm: A microRNA Regulatory Network Analysis. | Genes (Basel) | 2026 | 42510867 | PubTator, text mining | PubMed |
| Diagnostic value of miR-935 in polycystic ovary syndrome based on ultrasound findings and its mechanism in regulating KGN cell proliferation and apoptosis by STAT1. | Ir J Med Sci | 2026 | 42371269 | PubTator, text mining | PubMed |
| Apoptotic Signaling Across Breast Cancer Subtypes and Cryoablation-Induced Tissue Injury. | Int J Mol Sci | 2026 | 42352901 | PubTator, text mining | PubMed |
1 to 10 of 1,500
See all 1,500 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/100126325
GET https://conductscience.org/api/genes/v1/100126325/grants?page=2